Note: Ingredients listed on restricted chemical lists
EC/CAS
203-157-5/103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
83-84
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
50-<60
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
10-<20 3-<5
EC/CAS
232-679-6/9005-25-8
Name of the chemical
Starch
Concentration
3-<5
General Information
Revision date
2018-05-23
Product name
PANADOL COLD & FLU MAX+ DECONGESTANT POWDER
Product Synonyms
PANADOL COLD & FLU MAX + DECONGESTANT POWDER (ANZ) * R&D CODE A59/1 *
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.3 Other hazards
Assume that this product is capable of sustaining combustion. May form combustible dust concentrations in air. Caution - Pharmaceutical agent. See section 11 for additional information on health hazards.
